Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001567619-17-001088
Filing Date
2017-05-22
Accepted
2017-05-22 16:07:57
Documents
50
Period of Report
2017-05-22

Document Format Files

Seq Description Document Type Size
1 6-K s001712x1_6k.htm 6-K 11491
2 EXHIBIT 99.1 s001712x1_ex99-1.htm EX-99.1 366258
  Complete submission text file 0001567619-17-001088.txt   2183372

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT bysi-20170331.xml EX-101.INS 310410
4 XBRL TAXONOMY EXTENSION SCHEMA bysi-20170331.xsd EX-101.SCH 36616
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bysi-20170331_cal.xml EX-101.CAL 31783
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bysi-20170331_def.xml EX-101.DEF 221870
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bysi-20170331_lab.xml EX-101.LAB 166547
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bysi-20170331_pre.xml EX-101.PRE 235433
Mailing Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005
Business Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005 646-528-4184
BeyondSpring Inc. (Filer) CIK: 0001677940 (see all company filings)

EIN.: 463009483 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38024 | Film No.: 17860974
SIC: 2834 Pharmaceutical Preparations